Comment
doi: 10.1016/S2352-3026(20)30102-2.
Long-term efficacy and safety of ruxolitinib in polycythaemia vera
Affiliations
- PMID: 32589972
- DOI: 10.1016/S2352-3026(20)30102-2
Item in Clipboard
Comment
Long-term efficacy and safety of ruxolitinib in polycythaemia vera
Lancet Haematol.
2020 Jul.
No abstract available
Comment in
-
Long-term efficacy and safety of ruxolitinib in polycythaemia vera - Authors' reply.Lancet Haematol. 2020 Jul;7(7):e506. doi: 10.1016/S2352-3026(20)30141-1. Lancet Haematol. 2020. PMID: 32589974 No abstract available.
Comment on
-
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.Lancet Haematol. 2020 Feb;7(2):e100-e111. doi: 10.1016/S2352-3026(19)30220-0. Epub 2020 Jan 17. Lancet Haematol. 2020. PMID: 31958417 Clinical Trial.
Similar articles
-
Long-term efficacy and safety of ruxolitinib in polycythaemia vera - Authors' reply.Lancet Haematol. 2020 Jul;7(7):e506. doi: 10.1016/S2352-3026(20)30141-1. Lancet Haematol. 2020. PMID: 32589974 No abstract available.
-
Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study.Lancet Oncol. 2017 Jan;18(1):88-99. doi: 10.1016/S1470-2045(16)30558-7. Epub 2016 Dec 2. Lancet Oncol. 2017. PMID: 27916398 Clinical Trial.
-
ruxolitinib (JAKAVI°) and polycythaemia vera Inconclusive evaluation.Prescrire Int. 2016 Oct;25(175):229-231. Prescrire Int. 2016. PMID: 30645821
-
[Diagnosis and treatment of polycythaemia vera: state of the art].Orv Hetil. 2016 Oct;157(44):1743-1751. doi: 10.1556/650.2016.30583. Orv Hetil. 2016. PMID: 27796129 Review. Hungarian.
-
Ruxolitinib: evolution or revolution in treatment of patients with polycythemia vera?Future Oncol. 2016 Mar;12(6):739-49. doi: 10.2217/fon-2015-0023. Epub 2016 Feb 5. Future Oncol. 2016. PMID: 26846873 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
